Search results for " future"
Article
Accelerating CMC - The future of process development is in silico
Presented by Per Liden, General Manager, GoSilico at Cytiva.
Simulation for in silico process development is becoming a viable option to reduce the time needed for chemicals, manufacturin…
Article
Future Downstream Process Development Solutions for Advanced Therapies
downstream
Click here to view more Industry Leader Q&As >>
Peter Guterstam, PhD, Product Manager of Next Generation Resins & Technologies at Cytiva, provides insight into solutions for ad…
Resource
Advancing Future Therapeutics
Join our live process intensification webinars.
Article
Innovations in Cell Culture: Developing the Future
Join the discussion here >>
Thursday November 19, 2020 | 2:00 pm EST
Developing an upstream cell culture process is hard work. Join this discussion to explore the costs versus b…
Article
Preparing for the Future Visions and Insights for Biomanufacturing
Click here to learn more >>
The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targe…
Article
Highlights from the 5th International HTPD Conference, Part 3: Smart Process Development and a Look into the Future
Click here to read the full article >>
The high-throughput process development (HTPD) conference series is the key international forum for the presentation and discussion of topics relevant t…
Article
The Future of Biopharma
In this article, Günter Jagschies, former Senior Director, Strategic Consumer Relations at Cytiva, highlights the evolution of the biopharma industry. Günter discuss challenges and opportunities for…
Article
Next Generation Bioprocesses: Mapping Roads to the Future
Increased productivity demand and a diversifying clinical drug pipeline have pushed the industry to explore new strategies and technologies in biomanufacturing. So what are next-generation proc…
Article
Preparing for the Future: Visions and Insights for Biomanufacturing
The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targeting smaller patient populations,…
Article
A Q&A With Dr. Anurag Rathore About the Future of QbD, Part 2
This two-part Q&A series with Anurag Rathore, PhD, Professor, Department of Chemical Engineering, Indian Institute of Technology, Delhi, reveals the evolution of QbD, the types of companies implementi…